Biotechcompany Efferon has raised €2.5 million in a seed funding round led by privateinvestors from the DACH region to support the European commercial expansion ofEfferon LPS, its hemoadsorption devic...

Source: Tech.eu — read the full report at the original publisher.

This is a curated wire item. The Continuum Brief does not republish full third-party articles; this entry links to the original source.